This federal contract award, valued at $13,006.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management.
The contract is a delivery order with a firm-fixed price pricing type, and it has an ultimate completion date of December 17, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any major subcontractors mentioned.
This contract award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/17/25, 9:54 AM